Drug Shortage Report for APO-OLMESARTAN/HCTZ
| Report ID | 16905 |
| Drug Identification Number | 02453614 |
| Brand name | APO-OLMESARTAN/HCTZ |
| Common or Proper name | OLMESARTAN-HCTZ |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL |
| Strength(s) | 12.5MG 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 BTL & 30 BLS |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-12-18 |
| Estimated end date | 2018-04-30 |
| Actual end date | 2018-04-20 |
| Shortage status | Resolved |
| Updated date | 2018-04-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v24 | 2018-04-23 | French | Compare |
| v23 | 2018-04-23 | English | Compare |
| v22 | 2018-02-13 | French | Compare |
| v21 | 2018-02-13 | English | Compare |
| v20 | 2018-02-12 | French | Compare |
| v19 | 2018-02-12 | English | Compare |
| v18 | 2018-01-16 | French | Compare |
| v17 | 2018-01-16 | English | Compare |
| v16 | 2017-12-20 | French | Compare |
| v15 | 2017-12-20 | English | Compare |
| v14 | 2017-11-29 | French | Compare |
| v13 | 2017-11-29 | English | Compare |
| v12 | 2017-11-27 | French | Compare |
| v11 | 2017-11-27 | English | Compare |
| v10 | 2017-10-04 | French | Compare |
| v9 | 2017-10-04 | English | Compare |
| v8 | 2017-08-16 | French | Compare |
| v7 | 2017-08-16 | English | Compare |
| v6 | 2017-08-14 | French | Compare |
| v5 | 2017-08-14 | French | Compare |